Pattern Bioscience Secures $28.7 Million in Series C Financing

New funding will be used to accelerate development of first-of-its-kind infectious disease diagnostic platform that will deliver rapid antibiotic treatment guidance AUSTIN, Texas — April 27, 2023 — Pattern Bioscience, Inc., an innovator in rapid diagnosis and antibiotic susceptibility testing (AST) for bacterial infections, today announced the completion of a $28.7 million Series C financing. […] The post Pattern Bioscience Secures $28.7 Million in Series C Financing appeared first on Pattern Bioscience .